Together we will beat cancer

Donate

Charity promotes eco-fashion with collection at Love Not Landfill pop-up

Cancer Research UK presents charity collection in collaboration with influencer Shannon Alexandra at the Love Not Landfill fashion pop-up in London.

Read More

Three cancer drugs approved for NHS use in Scotland

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

Read More

Cancer Research UK’s charity Christmas cards now available

From snowy days in the country to festive wreaths and stockings, the shop has a design to suit every taste.

Read More

Immunotherapy approved for some people with oesophageal cancer on NHS in England

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

Read More

First targeted treatment approved for advanced prostate cancer on NHS in Scotland

The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.

Read More

New drug available for rare thyroid cancer on NHS in England

The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer.

Read More

Cancer target missed for 55,000 patients over 6 years

In the last 6 years, almost 55,000 cancer patients should have been diagnosed or started their treatment sooner, according to new calculations.

Read More

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

Read More

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

Read More

New chemotherapy-free treatment for bowel cancer made available in Scotland

Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.  

Read More